• 1. Fe3O4/FeS2 heterostructures enable efficient oxygen evolution reaction?
  Xingqun Zheng,Lele Song,Xin Feng,Li Li,Zidong Wei J. Mater. Chem. A, 2020,8, 14145-14151
• 2. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 3. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 4. Distinct impact of glycation towards the aggregation and toxicity of murine and human amyloid-β?
  Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640
• 5. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives 17-hydroxysteroids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives Hydroxysteroids 17-hydroxysteroids

Exploring the Unique Properties and Applications of 3-Methoxy-7a-methyl-estra-2,5(10)-dien-17b-ol (CAS No. 15506-02-2)

3-Methoxy-7a-methyl-estra-2,5(10)-dien-17b-ol (CAS No. 15506-02-2) is a specialized steroidal compound that has garnered significant attention in pharmaceutical and biochemical research. This unique molecule, characterized by its methoxy and methyl substitutions on the estra backbone, offers intriguing possibilities for therapeutic applications and scientific exploration. As researchers increasingly focus on modified steroidal compounds for targeted therapies, understanding the properties of this molecule becomes particularly relevant.

The molecular structure of 3-Methoxy-7a-methyl-estra-2,5(10)-dien-17b-ol features several distinctive modifications that influence its biological activity. The presence of a methoxy group at position 3 and a methyl group at position 7a creates a steric and electronic profile distinct from natural estrogens. These structural alterations make it an interesting subject for structure-activity relationship studies, particularly in the context of hormone receptor interactions and metabolic pathways.

Recent scientific literature highlights growing interest in modified estrogen derivatives like 3-Methoxy-7a-methyl-estra-2,5(10)-dien-17b-ol for their potential in addressing various health concerns. Researchers are particularly intrigued by how these synthetic modifications might influence receptor binding affinity and tissue selectivity, which are crucial factors in developing targeted therapies with reduced side effects. This aligns with current trends in precision medicine and personalized healthcare approaches.

The synthesis of 3-Methoxy-7a-methyl-estra-2,5(10)-dien-17b-ol typically involves multi-step organic transformations starting from appropriate steroidal precursors. Modern synthetic approaches emphasize green chemistry principles and atom economy, reflecting the pharmaceutical industry's growing commitment to sustainable manufacturing practices. Analytical characterization of this compound typically employs advanced techniques such as NMR spectroscopy, mass spectrometry, and X-ray crystallography to confirm its structure and purity.

In pharmacological research, 3-Methoxy-7a-methyl-estra-2,5(10)-dien-17b-ol serves as a valuable tool compound for investigating estrogen receptor modulation. Its unique structural features may offer insights into developing novel selective estrogen receptor modulators (SERMs) with improved therapeutic profiles. This is particularly relevant given current research trends focusing on women's health and age-related hormonal changes.

The compound's potential applications extend beyond human health, with research exploring its utility in veterinary medicine and agricultural science. Some studies suggest that appropriately modified steroidal compounds might find use in animal reproduction management or as plant growth regulators, though these applications require further investigation. This broad potential aligns with growing interest in multi-purpose bioactive compounds across different sectors.

Quality control and standardization of 3-Methoxy-7a-methyl-estra-2,5(10)-dien-17b-ol are critical for research applications. Reputable suppliers provide comprehensive analytical certificates detailing purity levels (typically >98%) and confirming the absence of impurities through techniques like HPLC analysis. Proper storage conditions (usually at 2-8°C in amber glass containers) help maintain the compound's stability over time.

From a regulatory perspective, 3-Methoxy-7a-methyl-estra-2,5(10)-dien-17b-ol is primarily used for research purposes and is subject to standard laboratory safety protocols. Researchers working with this compound should consult material safety data sheets and implement appropriate laboratory safety measures, including proper personal protective equipment and ventilation systems.

The future research directions for 3-Methoxy-7a-methyl-estra-2,5(10)-dien-17b-ol may include more detailed investigations of its metabolic fate and potential therapeutic applications. With advances in computational chemistry and molecular modeling, scientists can better predict how structural modifications might enhance desired biological activities while minimizing unwanted effects. This approach aligns with current trends in rational drug design and in silico screening methodologies.

For researchers seeking information about 3-Methoxy-7a-methyl-estra-2,5(10)-dien-17b-ol, common search queries often include its synthetic route, physicochemical properties, biological activity, and supplier information. The compound's CAS number (15506-02-2) serves as a crucial identifier in scientific literature and chemical databases, facilitating accurate information retrieval and avoiding confusion with similar compounds.

As the scientific community continues to explore modified steroidal compounds, 3-Methoxy-7a-methyl-estra-2,5(10)-dien-17b-ol remains an important reference molecule in this field. Its unique structural features and potential applications make it a valuable subject for ongoing research, particularly in areas related to hormone signaling, receptor pharmacology, and therapeutic development. Future studies may reveal additional applications for this interesting compound as our understanding of steroid biochemistry continues to evolve.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)